Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jhin.2020.09.035 http://scihub22266oqcxt.onion/10.1016/j.jhin.2020.09.035 33038435!7538869!33038435     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33038435&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Hosp+Infect 2021 ; 107 (?): 35-39 Nephropedia Template TP {{tp|p=33038435|t=2021. Targeted rapid testing for SARS-CoV-2 in the emergency department is associated with large reductions in uninfected patient exposure time |pdf=|usr=}}{{33038435}} gab.com Text Targeted rapid testing for SARS-CoV-2 in the emergency department is associated with large reductions in uninfected patient exposure time JO: J Hosp Infect http://www.kidney.de/pget.php?&tw=1&pmid=33038435 #FOAvip Opportunity exists to decrease healthcare-related exposure to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), preserve infection control resources, and increase care capacity by reducing the time to diagnosis of coronavirus disease 2019 (COVID-19). A retrospective cohort analysis was undertaken to measure the effect of targeted rapid molecular testing for SARS-CoV-2 on these outcomes. In comparison with standard platform testing, rapid testing was associated with a 65.6% reduction (12.6 h) in the median time to removal from the isolation cohort for patients with negative diagnostic results. This translated to an increase in COVID-19 treatment capacity of 3028 bed-hours and 7500 fewer patient interactions that required the use of personal protective equipment per week. Twit Text FOAVip Targeted rapid testing for SARS-CoV-2 in the emergency department is associated with large reductions in uninfected patient exposure time ????J Hosp Infect http://www.kidney.de/pget.php?&tw=1&pmid=33038435 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33038435 #FOAvip English Wikipedia <ref>{{Cite pmid|33038435}}</ref> Targeted rapid testing for SARS-CoV-2 in the emergency department is associated with large reductions in uninfected patient exposure time #MMPMID33038435 Hinson JS; Rothman RE; Carroll K; Mostafa HH; Ghobadi K; Smith A; Martinez D; Shaw-Saliba K; Klein E; Levin S J Hosp Infect 2021[Jan]; 107 (?): 35-39 PMID33038435show ga Opportunity exists to decrease healthcare-related exposure to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), preserve infection control resources, and increase care capacity by reducing the time to diagnosis of coronavirus disease 2019 (COVID-19). A retrospective cohort analysis was undertaken to measure the effect of targeted rapid molecular testing for SARS-CoV-2 on these outcomes. In comparison with standard platform testing, rapid testing was associated with a 65.6% reduction (12.6 h) in the median time to removal from the isolation cohort for patients with negative diagnostic results. This translated to an increase in COVID-19 treatment capacity of 3028 bed-hours and 7500 fewer patient interactions that required the use of personal protective equipment per week. |Adolescent[MESH] |Adult[MESH] |Aged[MESH] |COVID-19 Nucleic Acid Testing/*statistics & numerical data[MESH] |COVID-19/*diagnosis/*prevention & control[MESH] |Emergency Service, Hospital/*statistics & numerical data[MESH] |Female[MESH] |Humans[MESH] |Infection Control/*methods[MESH] |Infectious Disease Transmission, Patient-to-Professional/prevention & control[MESH] |Male[MESH] |Middle Aged[MESH] |Retrospective Studies[MESH] |SARS-CoV-2/genetics[MESH] |Time Factors[MESH]Targeted rapid testing for SARS-CoV-2 in the emergency department is a(epmc).pdf DeepDyve Pubget Overpricing